At a glance
ClinicalIndex Comparison RecordN/ACompleted· 119 enrolled
Drug / intervention
Parafilmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Parafilm Application to Prevent Central Line Associated Bloodstream Infections in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
In Brief
A clinical study evaluating Parafilm for Central Line Associated Bloodstream Infections (CLABSI) and Bone Marrow Transplant. Completed, enrolled 119 participants across 1 site.
Detailed Summary
The purpose of this study is to see if applying parafilm as an external barrier on the central line in children having a bone marrow transplant helps to prevent central line associated bloodstream infection(s) and also to assess the ease of use of parafilm.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedOct 2015
Primary CompletionMar 2018
TodayJul 2026
First PostedOct 14, 2015
Enrollment StartMar 1, 2015
Primary CompletionMar 29, 2018
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 10.7 years ago
Interventions
Parafilmdevice
Single-use, pre-cut sections of parafilm over the central venous catheter (CVC) hub (if not connected) or around the CVC hub connection (if connected). Parafilm will be maintained on the CVC until it is removed.